Teva Pharmaceutical Industries
TEVA
#705
Rank
HK$257.45 B
Marketcap
HK$224.40
Share price
0.98%
Change (1 day)
64.01%
Change (1 year)

Teva Pharmaceutical Industries (TEVA) - Cash on Hand

Cash on Hand as of September 2025 : HK$17.14 Billion

According to Teva Pharmaceutical Industries's latest financial reports the company has HK$17.14 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Teva Pharmaceutical Industries - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31HK$25.61 B1.68%
2023-12-31HK$25.19 B15.13%
2022-12-31HK$21.88 B29.64%
2021-12-31HK$16.88 B0.03%
2020-12-31HK$16.87 B9.72%
2019-12-31HK$15.38 B10.22%
2018-12-31HK$13.95 B85.47%
2017-12-31HK$7.52 B-1.8%
2016-12-31HK$7.66 B-85.77%
2015-12-31HK$53.83 B211.81%
2014-12-31HK$17.26 B114.51%
2013-12-31HK$8.04 B-63.93%
2012-12-31HK$22.31 B162.15%
2011-12-31HK$8.51 B-14.81%
2010-12-31HK$9.99 B-42.67%
2009-12-31HK$17.43 B18.28%
2008-12-31HK$14.73 B-34.26%
2007-12-31HK$22.41 B41.01%
2006-12-31HK$15.89 B-7.31%
2005-12-31HK$17.15 B112%
2004-12-31HK$8.08 B-24.34%
2003-12-31HK$10.69 B31.12%
2002-12-31HK$8.15 B32.35%
2001-12-31HK$6.16 B86.08%
2000-12-31HK$3.31 B351.47%
1999-12-31HK$0.73 B92.4%
1998-12-31HK$0.38 B-16.06%
1997-12-31HK$0.45 B-15.16%
1996-12-31HK$0.53 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Novartis
NVS
HK$75.89 B 342.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
HK$81.33 B 374.44%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
HK$34.58 B 101.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
HK$116.59 B 580.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$141.73 B 726.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
HK$6.11 B-64.33%๐Ÿ‡ฎ๐Ÿ‡ณ India
AstraZeneca
AZN
HK$63.66 B 271.40%๐Ÿ‡ฌ๐Ÿ‡ง UK